As reported on Science Daily, a groundbreaking study suggests that customizing breast cancer screening based on individual risk factors may outperform the traditional one-size-fits-all approach
Coya Therapeutics has achieved an important regulatory milestone with U.S. FDA acceptance of an Investigational New Drug (IND) application for COYA 302, marking the advancement
In a recent statement, the U.S. Food and Drug Administration (FDA) has authorized regular approval to rucaparib (Rubraca) for adults with metastatic castration-resistant prostate cancer
A new oral medication has demonstrated remarkable effectiveness in treating hereditary angioedema (HAE) attacks, offering patients significantly faster symptom relief compared to existing options. According
Incyte has announced encouraging top-line findings from its pivotal Phase III frontMIND trial, evaluating tafasitamab (marketed as Monjuvi/Minjuvi) in combination with lenalidomide and the standard
Researchers at Oregon Health & Science University have made a significant breakthrough in the fight against acute myeloid leukaemia (AML), discovering that combining a standard
I’ve always known that I wanted to help people. Growing up as the son of a veterinarian and a high school teacher who later became
Iowa University researchers at its Children’s Hospital led the effort that found a new target. According to the Iowa Carver College of Medicine, to date,
Editor’s Note: The following study results were first published in Nephrology Dialysis Transplantation (December 16, 2025) and later shared in the Oxford Academic. The original
Otsuka has claimed a significant victory in the increasingly competitive immunoglobulin A nephropathy (IgAN) field with FDA accelerated approval of Voyxact, the first-in-class anti-APRIL biologic
As reported on FiercePharma, Johnson & Johnson has secured a significant milestone in prostate cancer treatment with the FDA’s approval of Akeega for patients with
A groundbreaking study from Massachusetts General Hospital reveals that artificial intelligence is catching breast cancers that skilled radiologists initially overlook. As reported by Business Wire,
There’s a lot to consider when you’re facing tumor removal surgery. Think about mandible or jaw surgery, for example. Your face is part of every
As reported on PharmaBiz, GENESIS Pharma has announced an exclusive agreement with Otsuka Pharmaceutical Europe Ltd. (OPEL) to distribute and commercialize donidalorsen across 14 Central
As reported on PharmaBiz, Renalys Pharma has reported encouraging topline data from its Phase III trial evaluating sparsentan (RE-021), an oral dual endothelin and angiotensin
Gilead Sciences announced positive topline results from the Phase 3 ARTISTRY-2 trial on December 15, 2025 and reported by Drugs.com, marking a significant advancement in
As reported on BioPharmaDive, the U.S. Food and Drug Administration (FDA) has granted early approval for a new frontline treatment option for HER2-positive metastatic breast
A groundbreaking study published in Neurology and reported by Drugs.com reveals that adults with type 2 diabetes who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs),
Waiting for test results? The waiting is hard, the anxiety is real, the uncertainty weighs heavy. But you're stronger than this moment, and you're not alone!
#patientadvocacy #mentalhealth #youarenotalone #TestResults #PatientWorthy
❤️ Kawasaki Disease Awareness Day | January 26 ❤️
Today, we join families, advocates, and medical professionals around the world in recognizing Kawasaki Disease Awareness Day — a day dedicated to shining a light on the leading cause of acquired heart disease in children. Early detection is critical to preventing lifelong heart complications.
Kawasaki Disease can be difficult to identify because it often looks like other childhood illnesses. That’s why awareness matters. The more we know, the faster kids can get the lifesaving treatment they need.
✨ How you can show support today:
🔴 Wear red
🏠 Light up your home or workplace in white and red
📲 Share facts and stories using #LightsOnHeartsStrong to help raise awareness worldwide.
Together, we can help protect children's hearts and stand with every family affected by Kawasaki Disease. ❤️
#KawasakiDisease #PatientWorthy #ProtectTinyHearts
Go to your conference ! #PFIC PFIC Advocacy and Resource Network, Inc.⏰ One week until conference registration & travel scholarship applications open!
Mark your calendars for February 2nd when you can secure your spot at the 2026 PFIC Family & Scientific Conference in Chicago on July 9-10. Early bird pricing will be available through May 16th. Register early to save and receive a conference t-shirt!
We're committed to making this event accessible to as many families as possible. Travel scholarship applications will also open when registration goes live. The application deadline is March 2nd.
Get ready to join us for two days of connection, learning, and collaboration!
#communityconnection #liverdisease #pfic #raredisease #hepatologyconference #chicago
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
